Abiodun Ayo

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Cancers

Pharmaceutics

University of Helsinki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Sep 01 2015

Finland

PhD student :: Translational Cancer Medicine Research Program

Publications

Pirjo Nummela, Sadia Zafar, Erika Veikkolainen, Iiris Ukkola, Vincenzo Cinella, Abiodun Ayo, Muhammad Yasir Asghar, Niko Välimäki, Kid Törnquist, Auli Karhu, Pirjo Laakkonen, Lauri A Aaltonen, Ari Ristimäki
GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines. International journal of cancer 154 (11) (2024)
Pirjo Nummela, Sadia Zafar, Erika Veikkolainen, Iiris Ukkola, Vincenzo Cinella, Abiodun Ayo, Muhammad Yasir Asghar, Niko Välimäki, Kid Törnquist, Auli Karhu, Pirjo Laakkonen, Lauri A Aaltonen, Ari Ristimäki
GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines. International journal of cancer 154 (11) (2024)
Pirjo Nummela, Sadia Zafar, Erika Veikkolainen, Iiris Ukkola, Vincenzo Cinella, Abiodun Ayo, Muhammad Yasir Asghar, Niko Välimäki, Kid Törnquist, Auli Karhu, Pirjo Laakkonen, Lauri A Aaltonen, Ari Ristimäki
GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines. International journal of cancer 154 (11) (2024)
Pirjo Nummela, Sadia Zafar, Erika Veikkolainen, Iiris Ukkola, Vincenzo Cinella, Abiodun Ayo, Muhammad Yasir Asghar, Niko Välimäki, Kid Törnquist, Auli Karhu, Pirjo Laakkonen, Lauri A Aaltonen, Ari Ristimäki
GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines. International journal of cancer (2024)
Abiodun Ayo, Pirjo Laakkonen
Peptide-Based Strategies for Targeted Tumor Treatment and Imaging. Pharmaceutics 13 (4) (2021)
Abiodun Ayo, Eduard Figueras, Thomas Schachtsiek, Mazlum Budak, Norbert Sewald, Pirjo Laakkonen
Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI). Cancers 12 (7) (2020)

Abiodun Ayo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Abiodun Ayo